Fengyuan anticancer implant is still in clinical trials
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Fengyuan pharmaceutical disclosed on the interactive platform of panorama.com on August 20 that the company's anticancer implants are still in clinical trials It is reported that the implant is a kind of drug delivery system which is implanted surgically or introduced into the subcutaneous or other targeted parts through the needle It has the advantages of long-term, constant release, targeting, high bioavailability and can be stopped at any time Compared with traditional chemotherapy, implant has outstanding advantages and great potential in the field of cancer treatment in the future The main business of Fengyuan pharmaceutical is research, development, production and sales of biological medicine, traditional Chinese medicine, chemical synthetic medicine and its preparations.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
